Paradigm Biopharmaceuticals Ltd
OTC:PBIGF
Paradigm Biopharmaceuticals Ltd
OTC:PBIGF
Price:
0.1204
USD
Market Closed
Market Cap:
$42.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Paradigm Biopharmaceuticals Ltd
OTC:PBIGF
|
AU |
|
V
|
Vtech Holdings Ltd
OTC:VTKLY
|
HK |
|
PhosAgro PAO
MOEX:PHOR
|
RU |
|
A
|
Air China Ltd
SWB:AD2
|
CN |
|
Dexus
F:0DPS
|
AU |
|
S
|
SosTravel.com SpA
MIL:SOS
|
IT |
|
B
|
Brookfield Renewable Corp
TSX:BEPC
|
US |
|
EVN AG
LSE:0EEI
|
AT |
|
S
|
Sula Vineyards Ltd
BSE:543711
|
IN |
|
R
|
Ryman Hospitality Properties Inc
F:4RH
|
US |
|
D
|
Daikin Industries Ltd
OTC:DKILF
|
JP |
|
Koninklijke Ahold Delhaize NV
MIL:1AD
|
NL |
|
D
|
Darden Restaurants Inc
DUS:DDN
|
US |
|
P
|
Pioneer Property Group ASA
OSE:PPG
|
NO |
|
Bank of China Ltd
F:W8VS
|
CN |
|
Banco de Sabadell SA
MAD:SAB
|
ES |
|
Tod's SpA
F:TOB
|
IT |
|
B
|
Bombardier Inc
XHAM:BBDB
|
CA |
|
Constellation Software Inc
TSX:CSU
|
CA |
|
S
|
Swire Properties Ltd
OTC:SWPFF
|
HK |
|
I
|
Intercontinental Exchange Inc
F:IC2
|
US |
|
Alsea SAB de CV
OTC:ALSSF
|
MX |
|
A
|
AGBA Group Holding Ltd
F:D6D
|
HK |
|
B
|
Beigene Ltd
SWB:49BA
|
KY |
Wall St Price Targets
PBIGF Price Targets Summary
Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd
Wall Street analysts forecast PBIGF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PBIGF is 0.4696 USD with a low forecast of 0.465 USD and a high forecast of 0.4834 USD.
Lowest Forecast
Price Target
0.465
USD
286% Upside
Average Forecast
Price Target
0.4696
USD
290% Upside
Highest Forecast
Price Target
0.4834
USD
301% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBIGF's stock price target?
Price Target
0.4696
USD
0.4696
USD
According to Wall Street analysts, the average 1-year price target for PBIGF is 0.4696 USD with a low forecast of 0.465 USD and a high forecast of 0.4834 USD.
What is the Revenue forecast for Paradigm Biopharmaceuticals Ltd?
Projected CAGR
185%
185%
Over the last 10 years, the compound annual growth rate for Revenue has been 99%. The projected CAGR for the next 3 years is 185%.
